PRIMICERI, G. Et Al. 2022. Metastasectomy In Oligometastatic Rcc Brings A Survival Benefit In Immunotherapy Era: Results From The REMARCC-IO Registry.. European Association of Urology Congress - 2022 , (Amsterdam, Netherlands).

PRIMICERI, G., MARCHIONI, M., CAMPI, R., TAFURİ, A., AMPARORE, D., AUTORINO, R., ... MINERVINI, A.(2022). Metastasectomy In Oligometastatic Rcc Brings A Survival Benefit In Immunotherapy Era: Results From The REMARCC-IO Registry. . European Association of Urology Congress - 2022, Amsterdam, Netherlands

PRIMICERI, GIULIA Et Al. "Metastasectomy In Oligometastatic Rcc Brings A Survival Benefit In Immunotherapy Era: Results From The REMARCC-IO Registry.," European Association of Urology Congress - 2022, Amsterdam, Netherlands, 2022

PRIMICERI, GIULIA Et Al. "Metastasectomy In Oligometastatic Rcc Brings A Survival Benefit In Immunotherapy Era: Results From The REMARCC-IO Registry.." European Association of Urology Congress - 2022 , Amsterdam, Netherlands, 2022

PRIMICERI, G. Et Al. (2022) . "Metastasectomy In Oligometastatic Rcc Brings A Survival Benefit In Immunotherapy Era: Results From The REMARCC-IO Registry.." European Association of Urology Congress - 2022 , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={GIULIA PRIMICERI Et Al. }, title={Metastasectomy In Oligometastatic Rcc Brings A Survival Benefit In Immunotherapy Era: Results From The REMARCC-IO Registry.}, congress name={European Association of Urology Congress - 2022}, city={Amsterdam}, country={Netherlands}, year={2022}}